Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$9.40 – $15.62
7% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.61B | $2.82B | $3.57B | $4.01B | $4.44B | $4.78B | $5.39B | $6.03B |
| Cost of revenue | $1.06B | $1.18B | $1.35B | $1.51B | $1.89B | $2.06B | $2.19B | $2.65B |
| Gross profit | $1.55B | $1.64B | $2.21B | $2.50B | $2.55B | $2.71B | $3.20B | $3.37B |
| Gross margin | 59.4% | 58.0% | 62.0% | 62.4% | 57.5% | 56.8% | 59.4% | 56.0% |
| R&D | $111.0M | $103.0M | $157.0M | $225.0M | $281.0M | $295.0M | $325.0M | $136.7M |
| Operating income | $563.0M | $306.0M | $428.0M | $340.0M | −$26.0M | $302.0M | $645.0M | $782.5M |
| EBITDA | $683.0M | $538.0M | $599.0M | $500.0M | $492.0M | $644.0M | $682.0M | $1.16B |
| Net income | $337.0M | $317.0M | $241.0M | $247.0M | $93.0M | $168.0M | $235.0M | $607.8M |
| Net margin | 12.9% | 11.2% | 6.8% | 6.2% | 2.1% | 3.5% | 4.4% | 10.1% |
| EPS (diluted) | 1.36 | 1.28 | 0.97 | 0.98 | 0.37 | 0.64 | 0.88 | 2.28 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $6.4B | $2.31 | $2.28–$2.36 | 1 |
| 2027 | $7.2B | $3.14 | $3.09–$3.21 | 1 |
| 2028 | $8.0B | $4.07 | $4.01–$4.17 | 1 |
| 2029 | $8.8B | $4.89 | $4.82–$5.00 | 1 |
Forward consensus · source: Financial Modeling Prep
AMBU A S ORD
No one on the platform currently holds AMBFF.
No tracked institution reports a position in AMBFF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-05 | $0.4100 | 2025-12-08 |
| 2024-12-06 | $0.3800 | 2024-12-09 |
| Execution date | Ratio |
|---|---|
| 2018-01-03 | 5-for-1 |
No one on the platform has traded AMBFF yet.
| +0.00% |
| $4.3B |
| — |
| GGNDFGN Store Nord A/S | $13.63 | +0.00% | $2.0B | — |
| MAHLYMediPal Holdings Corporation | $16.28 | +0.00% | $3.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 7.1× earnings vs its 20.9× historical median P/E.
Fair value ≈ $28.80 · price $9.85 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.